Clozapine Use Pattern in the Province of Seville

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05083377

Enrollment

600

Registered

2021-10-19

Start date

2020-09-08

Completion date

2021-09-08

Last updated

2021-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia and Related Disorders

Keywords

clozapine

Brief summary

CLOZAPINE USE PATTERN IN THE PROVINCE OF SEVILLE

Detailed description

Subjects with a diagnosis of schizophrenia (F20 of ICD-10) under treatment with clozapine in the province of Seville. The use of clozapine, variability between centers and treatment modification will be identified.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Patients who have been prescribed (initially or regularly) clozapine during 2018, based on the casuistry provided by the Pharmacy service of the different hospitals.

Exclusion criteria

* Parkinson's disease * Dementia

Design outcomes

Primary

Measure	Time frame	Description
Identify the pattern of clozapine use in the province of Seville	year 2018	Identify the pattern of clozapine use in the province of Seville

Secondary

Measure	Time frame	Description
Analyze the variability between centers or professionals	year 2018	Analyze the variability between centers or professionals
Analyze the changes in the course of the disease since the prescription of clozapine	year 2018	Analyze the changes in the course of the disease since the prescription of clozapine

Countries

Spain

Outcome results